Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophilia

Haemophilia

Volumn 10, Issue 1, 2004, Pages 81-86

  Tagariello, Giuseppe ^a   Gerotto, M ^b   Pontisso, P ^b   Belvini, D ^a   Salviato, R ^a   Radossi, P ^a   Alberti, A ^b  

^a Castelfranco Veneto Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Haemophilia; Hepatitis C virus; Quasispecies

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENE AMPLIFICATION; GENE STRUCTURE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HETERODUPLEX ANALYSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; LIVER DISEASE; LONG TERM CARE; MOLECULAR EVOLUTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

EID: 1042292581     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00846.x     Document Type: Article

References (27)

1. Laurian Y, Blanc A, Delaney SR, Allein JP. All exposed haemophiliacs have markers of HCV. Vox Sang 1992; 62: 55-56.
2. Makris M, Garson JA, Ring CJA et al. Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood 1993; 81: 1898-902.
3. Hasiba UW, Spero JA, Lewis JH. Chronic liver dysfunction in multitransfused haemophiliacs. Transfusion 1977; 17: 490-4.
4. Makris M, Preston FE, Triger DR, Underwood JC, Choo QL, Kuo G. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335: 1117-9.
5. Rumi MG, Colombo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused haemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112: 379-80.
6. Colombo M, Mannucci PM, Brettler DB et al. Hepatocellular carcinoma in hemophilia. Am J Haematol 1991; 37: 243-6.
7. Darby SC, Ewart DW, Giangrande PLF et al. Mortality from liver disease in haemophilc men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997; 350: 1425-31.
8. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. for the Multicenter Hemophilia Cohort study. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effects of coinfection with human immununodeficiency virus. J Acquir Immune Defic Syndr 1993; 6: 602-10.
9. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko GM, Lee CA. The progression of HCV-associated liver disease in a cohort of haemophiliac patients. Br J Haematol 1994; 87: 555-61.
10. Tagariello G, Pontisso P, Davoli PG, Ruvoletto MG, Traldi A, Alberti A. Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs. Br J Haematol 1995; 91: 708-13.
11. Hayashi J, Kishihara Y, Yamaji K et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997; 25: 697-701.
12. Martell M, Esteban JI, Quer J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-9.
13. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996; 70: 7622-31.
14. Odeberg J, Yun Z, Sonnemborg A, Bioro K, Uhlen M, Lundeberg J. Variation of hepatitis C virus hypervariable region 1 in immunocompromized patients. J Infect Dis 1997; 175: 938-43.
15. Botarelli P, Brunetto MR, Minutello MA et al. T-lymphocyte response to hepatitis C virus in different clinical course of infection. Gastroenterology 1993; 104: 580-7.
16. Tagariello G, Pontisso P, Alberti A et al. Lower than expected HCV mixed infections in haemophiliacs tested by genotyping and serotyping. Haemopbilia 1998; 4(Suppl.): 256.
17. Preston FE, Jarvis LM, Preston FE et al. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood 1995; 85: 1259-62.
18. Toyoda H, Fukuda Y, Koyama Y et al. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic post-transfusion hepatitis C. Blood 1996; 88: 1488-93.
19. Hanley JP, Jarvis LM, Andrews J et al. Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods. Br J Haematol 1996; 94: 159-65.
20. Gerotto M, Sullivan DG, Polyak SJ et al. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C. J Virol 1999; 73: 7241-7.
21. Wilson JJ, Polyak SJ, Day TD, Gretch DR. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol 1995; 76: 1763-71.
22. Brambilla S, Bellati G, Asti M et al. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology 1998; 27: 1678-86.
23. Booth JC, Kumar U, Webster D, Monjardino J, Thomas HT. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998; 26: 223-7.
24. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 1072-5.
25. Lukashov VV, Kuiken CL, Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol 1995; 69: 6911-6.
26. Cuthbert RJ, Ludlam CA, Steel CM, Beatson D, Peutherer JF. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy. Br J Haematol 1992; 80: 364-9.
27. Mannucci PM, Gringeri A, Ammassari M, Mari D. Abnormalities of lymphocyte subsets are correlated with concentrate consumption in asymptomatic Italian hemophiliacs treated with concentrates made from American plasma. Am J Hematol 1984; 17: 167-76.